Cemiplimab Approved for Treatment of CSCC

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2018-140
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Cutaneous Squamous Cell Carcinoma (cSCC) and Immunosurveillance – The Impact of Immunosuppression on Frequency of cSCC

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2010English

COPD 2013: An Update on Treatment and Newly Approved Medications for Pharmacists

Journal of the American Pharmacists Association : JAPhA
PharmacologyPharmacy
2013English

Vorinostat Approved in Japan for Treatment of Cutaneous T-Cell Lymphomas: Status and Prospects

OncoTargets and Therapy
OncologyPharmacology
2012English

The First Biosimilar Approved for the Treatment of Osteoporosis: Results of a Comparative Pharmacokinetic/Pharmacodynamic Study

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2018English

Avastin Approved for Some Cervical Cancers

Cancer Discovery
Oncology
2014English

Savannah River Site Approved Site Treatment Plan, 2000 Annual Update

2000English

Epidemiology of BCC and cSCC in the U.K. 2013‐15

British Journal of Dermatology
DermatologyMedicine
2019English

128 CDC20 Played an Oncogenic Role in Human cSCC Progression

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy